|
Volumn 11, Issue 22, 2001, Pages 2975-2978
|
The discovery of anthranilic acid-based MMP inhibitors. Part 3: Incorporation of basic amines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINE;
ANTHRANILIC ACID DERIVATIVE;
ANTINEOPLASTIC AGENT;
ANTIRHEUMATIC AGENT;
CGS 27023A;
COLLAGENASE 3;
GELATINASE B;
INTERSTITIAL COLLAGENASE;
MATRIX METALLOPROTEINASE INHIBITOR;
METALLOPROTEINASE INHIBITOR;
PIPERAZINE DERIVATIVE;
TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CATTLE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
ENZYME INHIBITION;
IN VITRO STUDY;
IN VIVO STUDY;
MOUSE;
NONHUMAN;
RAT;
ADAM PROTEINS;
AMINES;
ANIMALS;
ANTHRANILIC ACIDS;
BINDING SITES;
COLLAGENASES;
ENZYME INHIBITORS;
HYDROXAMIC ACIDS;
INTERLEUKIN-1;
INTERLEUKIN-1BETA;
MAGNETIC RESONANCE SPECTROSCOPY;
MATRIX METALLOPROTEINASE 1;
MATRIX METALLOPROTEINASE 13;
MATRIX METALLOPROTEINASE 9;
METALLOENDOPEPTIDASES;
MICE;
MODELS, MOLECULAR;
OSTEOARTHRITIS;
RATS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0035914612
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(01)00601-1 Document Type: Article |
Times cited : (34)
|
References (20)
|